Compare Align Technology, Inc. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROE of 12.95%
2
Company has a low Debt to Equity ratio (avg) at times
3
Poor long term growth as Operating profit has grown by an annual rate 9.66% of over the last 5 years
4
Flat results in Dec 25
5
With ROE of 11.79%, it has a fair valuation with a 2.98 Price to Book Value
6
High Institutional Holdings at 100%
7
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
USD 12,079 Million (Small Cap)
25.00
NA
0.00%
-0.27
11.79%
2.98
Revenue and Profits:
Net Sales:
1,040 Million
(Quarterly Results - Mar 2026)
Net Profit:
113 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.03%
0%
-10.03%
6 Months
25.17%
0%
25.17%
1 Year
-6.72%
0%
-6.72%
2 Years
-38.32%
0%
-38.32%
3 Years
-44.86%
0%
-44.86%
4 Years
-39.81%
0%
-39.81%
5 Years
-71.79%
0%
-71.79%
Align Technology, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.30%
EBIT Growth (5y)
9.66%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
1.02
Tax Ratio
30.70%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
25.44%
ROE (avg)
12.95%
Valuation key factors
Factor
Value
P/E Ratio
25
Industry P/E
Price to Book Value
2.98
EV to EBIT
17.89
EV to EBITDA
14.66
EV to Capital Employed
3.72
EV to Sales
2.72
PEG Ratio
2.03
Dividend Yield
NA
ROCE (Latest)
20.78%
ROE (Latest)
11.79%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 155 Schemes (59.16%)
Foreign Institutions
Held by 426 Foreign Institutions (25.78%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
1,040.10
1,047.60
-0.72%
Operating Profit (PBDIT) excl Other Income
241.60
261.60
-7.65%
Interest
0.00
0.00
Exceptional Items
-35.10
-70.70
50.35%
Consolidate Net Profit
112.80
135.80
-16.94%
Operating Profit Margin (Excl OI)
177.90%
216.80%
-3.89%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -0.72% vs 5.21% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is -16.94% vs 139.08% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
4,035.00
3,999.00
0.90%
Operating Profit (PBDIT) excl Other Income
851.40
816.80
4.24%
Interest
0.00
0.00
Exceptional Items
-179.30
-28.90
-520.42%
Consolidate Net Profit
410.40
421.40
-2.61%
Operating Profit Margin (Excl OI)
171.20%
168.00%
0.32%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.90% vs 3.54% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -2.61% vs -5.32% in Dec 2024
About Align Technology, Inc. 
Align Technology, Inc.
Pharmaceuticals & Biotechnology
Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.
Company Coordinates 
Company Details
2820 Orchard Pkwy , SAN JOSE CA : 95134-2019
Registrar Details






